Marianna Shelenkova's practice focuses on corporate and financial transactions, particularly on public and private securities offerings, representing both issuers and underwriters in initial public offerings, follow-on offerings, private placements and sovereign debt offerings. She also regularly advises clients on a broad range of general corporate law, corporate governance and Securities and Exchange Commission compliance matters, including assisting public companies in the preparation of their periodic securities law filings.

Experience

  • Cyrus Capital Partners L.P., as a selling stockholder in connection with Virgin America Inc.'s initial public offering of US$300,000,000 on the NASDAQ Global Select Market.
  • VimpelCom Holdings B.V., a multi-national telecommunications company, in its offering of US$600,000,000 5.20% notes, US$1,000,000,000 5.95% notes and RUB 12,000,000,000 9.00% notes in a Rule 144A/Regulation S private placement.
  • Memorial Resource Development Corporation, in its private issuance of US$600,000,000 5.875% senior notes.
  • Barclays Bank in the issuance by the Republic of Turkey of US$1,000,000,000 6.25% notes and HSBC Bank PLC in the issuance of US$1,500,000,000 6.25% notes.
  • Multiple lead managers in the issuance by the Republic of Latvia of US$1,000,000,000 5.25% notes.
  • Merck & Co. in the US$8.5 billion financing associated with its US$41 billion merger with Schering-Plough.

Perspectives

Key Reminders for Financial Institutions for 2016 10-Ks and the 2017 Proxy Season
Advisory
USA Corporate M&A Chapter
Chambers Global Practice Guides 2017

Credentials

Education
  • JD, Northeastern University School of Law, 2008
  • BA, University of Pennsylvania, 2001
Admissions
  • New York
Activities
  • Member, American Bar Association

Overview

Email Disclaimer